Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
Holders of 5% or more of STAB
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Statera Biopharma, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Statera Biopharma, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Statera Biopharma, Inc., newest first, including old-format filings without a stake.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Statera Biopharma, Inc. shares.
No Form 144 notices for Statera Biopharma, Inc. are on file.